Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,382 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06952881Recruiting
Studying COPD types and treatable traits
This study looks at different forms of COPD to find better ways to treat them. It may help you understand your own condition and receive more personalized care.
Hong KongAges 40 years+ - NCT07147608Recruiting
Simplifying physical activity assessment for hospital patients
This study tests a quick questionnaire about your walking habits to see if it can reliably replace wearing an activity monitor for several days. It may help make physical activity assessment easier during routine care.
AngersAges 18 years+ - NCT07145918RecruitingPhase 2
Study of an oral schizophrenia drug for adults
This trial tests an experimental oral drug (emraclidine) to see if it helps symptoms of schizophrenia and how it moves through the body. It looks at two groups of participants: those with stable symptoms and those having an acute flare-up.
Little Rock, ArkansasAges 18–65 - NCT07155174RecruitingPhase 2
Testing new drug combo for first-line extensive small cell lung cancer
This trial tests a new combination treatment (ABBV-706 plus atezolizumab) as a first option for people with extensive stage small cell lung cancer. It compares this new approach to the usual standard treatment, aiming to see if it works better and has fewer side effects.
New Haven, ConnecticutAges 18 years+ - NCT07146854Recruiting
EndoForce Connector Study for Dialysis Graft Access
This study is testing a new connector system (EndoForce) used during dialysis graft placement in people with kidney failure. Researchers want to make sure it works safely and effectively in real-world use.
Orangeburg, South CarolinaAges 18 years+ - NCT07149701Recruiting
Ventricular Tachycardia patient registry study
This study is for adults with ventricular tachycardia (a fast heart rhythm) who also have structural heart disease. It will track your health over time to learn more about how this condition is managed.
BeijingAges 18 years+ - NCT07148180RecruitingPhase 1/Phase 2
Targeting leftover leukemia cells with a combination therapy
This trial tests a new drug combo (tagraxofusp, azacitidine, and venetoclax) for people with acute myeloid leukemia (AML) who have very small amounts of cancer cells still present after initial treatment. The goal is to see if it can clear these leftover cells and prevent the cancer from coming back.
Boston, MassachusettsAges 18 years+ - NCT05456893Recruiting
Testing blood and stool markers in active ulcerative colitis treatments
This study checks biomarkers (signals in blood and/or stool) in adults with moderate-to-severe ulcerative colitis. It compares patients starting targeted medicines and looks for marker patterns that may reflect how the disease is behaving.
Nancy, LorraineAges 18 years+ - NCT06959628Recruiting
Study of a new shunt system for carotid artery blockage treatment
This trial tests a special shunt system to protect your brain during carotid artery stenting. It may help people with severe blockages in the neck artery that supplies blood to the brain.
BeijingAges 18 years+ - NCT07140614RecruitingPhase 1
Study of EDK060 for adults with CMT1A
This trial tests a new medicine called EDK060 for people with Charcot-Marie-Tooth disease type 1A (CMT1A). The study will check if the drug is safe and how the body processes it, with the goal of finding better treatments for this condition.
Ottawa, OntarioAges 18–60 - NCT07144462RecruitingEarly Phase 1
Testing a new drug for people with certain autoimmune diseases that have come back or not responded to treatment
This trial is testing a new injection, NEUK203-215, in adults aged 18-65 with certain autoimmune diseases (like lupus, scleroderma, inflammatory myopathy, or a skin blistering condition) that have relapsed or not responded to standard therapy. The goal is to see if it is safe, tolerable, and may help control the disease.
Shanghai, Shanghai MunicipalityAges 18–65 - NCT07136467Recruiting
Understanding daily life with vitiligo, alopecia areata, or hidradenitis suppurativa
This study looks at how certain skin conditions affect daily life in teens and adults. Researchers want to understand the challenges people face with vitiligo, alopecia areata, or hidradenitis suppurativa by having participants fill out simple questionnaires.
Ciudad Autonoma de Buenos Aire, Buenos AiresAges 12 years+ - NCT07136116Recruiting
Study of risankizumab for moderate to severe ulcerative colitis in Japan
This study looks at how well risankizumab (an injected medicine) works for people with moderate to severe ulcerative colitis. It tracks your symptoms using a mobile app to see if the drug helps control the disease.
Nagakute, Aichi-kenAges 15 years+ - NCT07143617Recruiting
Safety study of STR-P004 for lupus and inflammatory muscle disease
This trial tests the safety of a new treatment called STR-P004 for people with systemic lupus erythematosus (SLE) or certain inflammatory muscle diseases that have not improved with standard therapies. It may be an option if your condition is hard to control.
BeijingAges 18 years+ - NCT07140731Recruiting
Symani Restore study for moyamoya disease surgery
This study tests if the Symani surgical system helps surgeons perform a delicate brain blood-vessel bypass in people with moyamoya disease. It may offer a precise, minimally invasive option for those needing neurosurgery.
Buffalo, New YorkAges 18 years+ - NCT07143266Recruiting
Sleep study for people with pituitary and hypothalamus conditions
This study looks at sleep problems in people whose hypothalamus or pituitary gland does not work normally. It compares their sleep with healthy volunteers to better understand how these conditions affect rest.
BarcelonaAges 18–70 - NCT07143968RecruitingPhase 2
Resmetirom for people with MASLD and HIV
This study tests if resmetirom can help people who have both HIV and a liver condition called MASLD (fat buildup in the liver not caused by alcohol). You may qualify if your liver has a certain amount of fat and stiffness, and your HIV is well controlled with stable medication.
Birmingham, AlabamaAges 18 years+ - NCT06961409Recruiting
Saliva markers test for gum health
This trial measures certain proteins in your saliva to understand how they relate to different stages of gum disease. If you're generally healthy and have not smoked or taken certain medications recently, you may be able to join and help researchers learn more about gum health.
Izmir, ÇiğliAges 18–70 - NCT07127172Recruiting
Brain implant study for controlling devices with your mind
This study tests a brain implant that lets you control external devices like a computer or tablet just by thinking. It is for people with paralysis or severe weakness in both arms due to conditions like spinal cord injury, ALS, or stroke.
London, Greater LondonAges 18 years+ - NCT07134335RecruitingPhase 2
Study of UBT251 injection for chronic kidney disease
This study tests an investigational injection called UBT251 for people with chronic kidney disease who are overweight. It aims to see if it can reduce protein in the urine and help protect kidney function.
BeijingAges 18–75 - NCT07132879Recruiting
Telehealth in MND research database
This study is building a database of people with motor neurone disease (MND) in the UK to help with future research. You can take part from home using telehealth (remote appointments).
SheffieldAges Any age - NCT07133984Recruiting
Heart imaging study for patients with low heart function and coronary artery disease
This study uses cardiac MRI to look at the heart in people with weakened heart muscle and blocked heart arteries. It may help doctors improve treatments like bypass surgery or stents.
Brooklyn, New YorkAges 18 years+ - NCT07130968Enrolling by invitation
Heart and lung function study with exercise test and five-year follow-up
This study looks at how your heart and lungs work during exercise by using a special test called a cardiopulmonary exercise test (CPET). Researchers will follow you for up to five years to see how your health changes. It may help you understand your heart condition better and get more personalized care.
Guangzhou, GuangdongAges 18–80 - NCT07133516Recruiting
AI heart ultrasound study for adults ages 18-80
This study uses artificial intelligence to help evaluate heart ultrasounds. It is testing whether AI can accurately measure heart function in adults with various heart conditions, such as coronary disease, valve problems, high blood pressure, atrial fibrillation, heart failure, or cardiomyopathy.
Huainan, AnhuiAges 18–80
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,382 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.